Abivax SA American Depositary Shares (ABVX) Stock Forecast & Price Target
Abivax SA American Depositary Shares · NASDAQ
$124.14-3.86 (-3.02%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Abivax SA American Depositary Shares, 11 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $110.00 to $187.00, a moderate spread. The average target of $152.33 sits 23% above the current $124.14. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees revenue growth near -17% this year and 3008% next, consensus EPS building from about $-0.67 next quarter toward $-3.15 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Strong Buy
Strong Buy00%
Buy1192%
Hold18%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to Abivax SA American Depositary Shares.
As of Jul, 11 of 12 firms rate ABVX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ABVX EPS & revenue forecast
EPS · NEXT QUARTER
$-0.67
Range $-0.88 – $-0.48 · 3 analysts · -73% YoY
Next period, 3 analysts expect Abivax SA American Depositary Shares to earn $-0.67 a share (range $-0.88 – $-0.48), versus $-2.47 a year earlier. Full-year consensus is $-3.58, growing to $-3.15 the year after.
REVENUE · NEXT QUARTER
$817.3K
Range $0 – $1.9M · 3 analysts · -63% YoY
Revenue is expected to reach $817.3K (range $0 – $1.9M), -63.0% year-over-year. Full-year consensus is $74.9M, rising to $82.7M next year.
Top analysts covering Abivax SA American Depositary Shares
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ABVX.
#1
Jason Butler
JMP Securities · Rank #22
Buy
$187.00+50.6% to target
Overall win rate
57%
+ Follow
#2
Yatin Suneja
Guggenheim · Rank #28
Buy
$175.00+41.0% to target
Overall win rate
52%
+ Follow
#3
Roy Buchanan
JMP Securities · Rank #109
Buy
$33.00-73.4% to target
Overall win rate
48%
+ Follow
#4
David Nierengarten
Wedbush · Rank #115
Hold
$110.00-11.4% to target
Overall win rate
41%
+ Follow
#5
Julian Harrison
BTIG
Buy
$175.00+41.0% to target
Coverage
—
+ Follow
ABVX stock forecast FAQ
What is ABVX's average 12-month price target?+
The 12 analysts with a live target average $152.33 for Abivax SA American Depositary Shares over the next 12 months, ranging from a $187.00 high to a $110.00 low.
Is ABVX stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 12 analyst ratings, 11 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ABVX?+
The Street-high target is $187.00 (Citizens), and the Street-low is $110.00 (Wedbush). The average of all 12 active targets is $152.33.
How many Wall Street analysts cover ABVX?+
12 analysts have an active rating on Abivax SA American Depositary Shares, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering ABVX?+
Among analysts who currently cover ABVX, Jason Butler of JMP Securities has the strongest overall Quantellect track record (Rank #22). Their current call is Buy with a $187.00 target.
What is Abivax SA American Depositary Shares's projected EPS for next quarter?+
The consensus estimate is $-0.67 per share (range $-0.88 – $-0.48) across 3 analysts. Full-year EPS is projected at $-3.58, rising to $-3.15 the following year.
How much revenue is Abivax SA American Depositary Shares expected to report next quarter?+
Consensus revenue is $817.3K (range $0 – $1.9M). Full-year revenue is projected at $74.9M, growing to $82.7M next year.
Have analysts been upgrading or downgrading ABVX lately?+
As of Jul, 11 of 12 firms rate ABVX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ABVX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
